Top Markets
#1 Official Trump Official Trump +33.51%
#2 Tutorial Tutorial +32.07%
#3 Siacoin Siacoin +22.29%
#4 EXOD EXOD +22.08%
#5 Mubarak Mubarak +21.21%
#6 Unit Pump Unit Pump +21.01%
#7 Melania Meme Melania Meme +20.39%
#8 Stacks Stacks +19.79%
#9 MowCat MowCat +19.08%
#10 Pump.fun Pump.fun +18.96%
Coin of the day
Official Trump Official Trump
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
Classifica tra le azioni #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
Prezzo delle azioni
$0.04959193
Ultima sincronizzazione: 2025-03-17
Capitalizzazione di mercato
$79.94M
Variazione (1 giorno)
13.49%
Variazione (1 anno)
0.00%
Paese
SE
Scambia Abliva AB (publ) (ABLI)

Categoria

Healthcare
Storico del prezzo dell'azione per Abliva AB (publ) (ABLI)
Prezzo di chiusura più alto: $0.04 il 2025-03-01

Prezzo di chiusura più basso: $0.44 il 2008-10-01
Storico del prezzo dell'azione di Abliva AB (publ) dal 2008 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2025 83.38%
2024 -0.37%
2023 44.87%
2022 -73.02%
2021 -34.26%
2020 -30.47%
2019 -20.24%
2018 -46.40%
2017 4.60%
2016 -62.61%
2015 -86.83%
2014 208.88%
2013 -8.57%
2012 59.62%
2011 -55.60%
2010 208.76%
2009 91.09%
2008 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH